Free Trial

Royalty Pharma (RPRX) Dividend Yield, Date & History

Royalty Pharma logo
$24.92 +0.64 (+2.64%)
(As of 12/20/2024 05:51 PM ET)

Royalty Pharma Dividend Summary

Dividend Yield
3.37%
Annual Dividend
$0.84
Recent
Dividend Payment
Dec. 10
Annualized 3-Year
Dividend Growth
38.67%
Dividend Payout Ratio
43.52%

Royalty Pharma (RPRX) pays an annual dividend of $0.84 per share, with a dividend yield of 3.37%. The next quarterly payment of $0.21 per share was paid on Tuesday, December 10, to investors who owned the stock before the ex-dividend date of Friday, November 15. The company currently pays out 43.52% of its earnings and 18.34% of its cash flow as dividends.

Get Dividend Stock Ideas Daily

Enter your email address below to receive the DividendStocks.com newsletter, a daily email that contains dividend stock ideas, ex-dividend stocks, and the latest dividend investing news.

Sign Up
Skip Charts & View Dividend History

RPRX Dividend Payments by Quarter

The chart below displays up to four years of Royalty Pharma's dividend payment history by quarter. The blue bars represent historical dividend payments, while the gray bars indicate future payments.

RPRX Dividend Yield Over Time

The chart below tracks Royalty Pharma's dividend yield over the past four years. The line represents changes in yield by quarter, providing a clear view of trends over time.

Royalty Pharma vs. The Competition

Compare Royalty Pharma's annual dividend, yield, and 3-year growth rate with averages for Finance and NASDAQ companies to evaluate its performance against the market.

TypeRoyalty PharmaFinance CompaniesNASDAQ Companies
Annual Dividend$0.84$0.02$1.31
Dividend Yield3.37%10.09%4.21%
Annualized 3-Year Dividend Growth38.67%12.89%14.22%

Royalty Pharma Dividend Payout Ratio

Dividend payout ratios express the dividend as a percentage of another metric, such as earnings or cash flow, and can be used to assess dividend sustainability.

TypePayout Ratio
Based on Trailing 12 Months of Earnings43.52%
Based on This Year's Estimate20.49%
Based on Next Year's Estimate19.49%
Based on Cashflow18.34%

Royalty Pharma Dividend History by Quarter

AnnouncedPeriodPaymentPayment ChangeYieldEx-Dividend DateRecord DatePayable Date
10/11/2024Quarterly$0.21 - 3%11/15/202411/15/202412/10/2024
7/17/2024Quarterly$0.21 - 2.97%8/16/20248/16/20249/13/2024
4/17/2024Quarterly$0.21 - 3.04%5/16/20245/17/20246/14/2024
1/19/2024quarterly$0.21+$0.01
5.00%
2.9%2/15/20242/16/20243/15/2024
10/16/2023Quarterly$0.20 - 2.81%11/16/202311/17/202312/15/2023
7/17/2023Quarterly$0.20 - 2.59%8/17/20238/18/20239/15/2023
4/17/2023Quarterly$0.20 - 2.19%5/18/20235/19/20236/15/2023
1/9/2023Quarterly$0.20+$0.01
5.26%
2.04%2/15/20232/16/20233/15/2023

This table shows Royalty Pharma's quarterlydividend history, including payout amounts, yield, dividend changes, and key dates. Use the date filter to explore data as far back as 2013 to analyze trends over time.

Royalty Pharma Dividend - Frequently Asked Questions

The current dividend yield for Royalty Pharma is 3.37%. Learn more on RPRX's dividend yield history.

The annual dividend for RPRX shares is $0.84. Learn more on RPRX's annual dividend history.

Royalty Pharma pays quarterly dividends to shareholders.

Royalty Pharma's most recent quarterly dividend payment of $0.21 per share was made to shareholders on Tuesday, December 10, 2024.

Royalty Pharma's most recent ex-dividend date was Friday, November 15, 2024.

Over the past three years, the company's dividend has grown by an average of 38.67% per year.

The most recent change in the company's dividend was an increase of $0.01 on Friday, January 19, 2024.

The dividend payout ratio for RPRX is:
  • 43.52% based on the trailing year of earnings
  • 20.49% based on this year's estimates
  • 19.49% based on next year's estimates
  • 18.34% based on cash flow

Royalty Pharma's dividend yield of 3.43% is lower than the average Finance company that issues a dividend. Royalty Pharma's dividend payout ratio of 43.52% is at a healthy, sustainable level, below 75% of its earnings.

Looking at the stock as a whole, market analysts rate Royalty Pharma stock as a Moderate Buy, forecasting growth opportunities and potential value appreciation.


This page (NASDAQ:RPRX) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners